Swedish experience-based value sets for EQ-5D health states

Quality of Life Research

Volumn 23, Issue 2, 2014, Pages 431-442

  Burström, Kristina ^a,b   Sun, Sun ^a,b   Gerdtham, Ulf G ^c   Henriksson, Martin ^d   Johannesson, Magnus ^e   Levin, Lars Åke ^f   Zethraeus, Niklas ^a,g  

^a KAROLINSKA INSTITUTE   (Sweden)

^b STOCKHOLM COUNTY COUNCIL   (Sweden)

^c LUND UNIVERSITY   (Sweden)

^d ASTRAZENECA R AND D   (Sweden)

^e STOCKHOLM SCHOOL OF ECONOMICS   (Sweden)

^f LINKÖPING UNIVERSITY   (Sweden)

^g Swedish Dental and Pharmaceutical Benefits Agency   (Sweden)

Author keywords

EQ 5D; Experience based value set; General population; Self rated health; Time trade off; Visual analogue scale

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; FEMALE; HEALTH STATUS; HEALTH SURVEY; HUMAN; MALE; METHODOLOGY; MIDDLE AGED; QUALITY OF LIFE; QUESTIONNAIRE; SELF REPORT; STATISTICAL MODEL; SWEDEN; VERY ELDERLY; VISUAL ANALOG SCALE; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FEMALE; HEALTH STATUS; HEALTH SURVEYS; HUMANS; MALE; MIDDLE AGED; MODELS, STATISTICAL; QUALITY OF LIFE; QUESTIONNAIRES; SELF REPORT; SWEDEN; VISUAL ANALOG SCALE; YOUNG ADULT;

EID: 84900367783     PISSN: 09629343     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11136-013-0496-4     Document Type: Article

References (62)

1. Rabin, R.; de Charro, F. (2001). EQ-5D: A measure of health status from the EuroQol group. Annals of Medicine, 33(5), 337-343.
2. Burström, K.; Johannesson, M.; Diderichsen, F. (2003). The value of the change in health in Sweden 1980/81 to 1996/97. Health Economics, 12(8), 637-654.
3. Devlin, N. J.; Parkin, D.; Browne, J. (2010). Patient-reported outcome measures in the NHS: new methods for analysing and reporting EQ-5D data. Health Economics, 19(8), 886-905.
4. Drummond, M. F.; Sculpher, M. J.; Torrance, G. W.; O'Brien, B. J.; Stoddart, G. L. (2005). Methods for the economic evaluation of health care programmes (3rd ed.). New York: Oxford Medical Publications.
5. Broome, J. (1993). QALYs. Journal of Public Economics, 50, 149-167.
6. Williams, A. (1985). Economics of coronary artery bypass grafting. British Medical Journal, 291(6491), 326-329.
7. Dolan, P. (2000). The measurement for health-related quality-of-life for use in resource allocation decisions in health care. In A. J. Culyer & J. Newhouse (Eds.), Handbook of health economics (pp. 1723-1760). Amsterdam: North-Holland.
8. Mann, R.; Brazier, J.; Tsuchiya, A. (2009). A comparison of patient and general population weightings of EQ-5D dimensions. Health Economics, 18(3), 363-372.
9. Szende, A.; Oppe, M.; Devlin, N. (Eds.). (2007). EQ-5D value sets: Inventory, comparative review and user guide. Dordrecht: Springer.
10. Ubel, P. A.; Loewenstein, G.; Hershey, J.; Baron, J.; Mohr, T.; Asch, D.; et al. (2001). Do nonpatients underestimate the quality of life associated with chronic health conditions because of a focusing illusion? Medical Decision Making, 21(3), 190-199.
11. Stolk, E. A.; Oppe, M.; Scalone, L.; Krabbe, P. F. M. (2010). Discrete choice modeling for the quantification of health states: The case of the EQ-5D. Value in Health, 13(8), 1005-1013.
12. Brazier, J.; Akehurst, R.; Brennan, A.; Dolan, P.; Claxton, K.; McCabe, C.; et al. (2005). Should patients have a great role in valuing health states? Applied Health Economics and Health Policy, 4(4), 201-208.
13. Burström, K.; Johannesson, M.; Diderichsen, F. (2006). A comparison of individual and social time trade-off values for health states in the general population. Health Policy, 76(3), 359-370.
14. Dolan, P. (2008). Developing methods that really do value the 'Q' in the QALY. Health Economics, Policy and Law, 3, 69-77.
15. Dolan, P.; Kahneman, D. (2008). Interpretations of utility and their implications for the valuation of health. The Economic Journal, 118, 215-234.
16. Dolan, P. (2011). Thinking about it: Thoughts about health and valuing QALYs. Health Economics, 20(12), 1407-1416.
17. Insinga, R. P.; Fryback, D. G. (2003). Understanding differences between self-ratings and populations ratings for health in the EuroQOL. (2003). Quality of Life Research, 12(6), 611-619.
18. Johannesson, M.; Jonsson, B.; Karlsson, G. (1996). Outcome measurement in economic evaluation. Health Economics, 5(4), 279-296.
19. Krabbe, P. F. M.; Tromp, N.; Ruers, T. J. M.; van Riel, P. L. C. M. (2011). Are patients' judgements of health status really different from the general population? Health and Quality of Life Outcomes, 9, 31.
20. McNamee, P. (2007). What difference does it make? The calculation of QALY gains from health profiles using patient and general population values. Health Policy, 84(2-3), 321-331.
21. McPherson, K.; Myers, J.; Talor, W. J.; McNaughton, H. K.; Weatherall, M. (2004). Self-valuation and societal valuations of health state differ with disease severity in chronic and disabling conditions. Medical Care, 42(11), 1143-1151.
22. de Wit, G. A.; Busschbach, J. J.; de Charro, F. T. (2000). Sensitivity and perspective in valuation of health status: Whose values count? Health Economics, 9(2), 109-126.
23. Dolan, P. (1997). Modeling valuations for EuroQol health states. Medical Care, 35(11), 1095-1108.
24. Greiner, W.; Weijnen, T.; Nieuwenhuizen, M.; Oppe, S.; Busschbach, J.; Buxton, M.; et al. (2003). A single European currency for EQ-5D health states. European Journal of Health Economics, 4(3), 222-231.
25. Zarate, V.; Kind, P.; Chuang, L. H. (2008). Hispanic valuation of the EQ-5D health states: a social value set for Latin Americans. Value in Health, 11(7), 1170-1177.
26. Badia, X.; Roset, M.; Herdman, M.; Kind, P. (2001). A comparison of United Kingdom and Spanish general population time trade-off values for EQ-5D health states. Medical Decision Making, 21(1), 7-16.
27. Bailey, H.; Kind, P. (2010). Preliminary findings of an investigation into the relationship between national culture and EQ-5D value sets. Quality of Life Research, 19(8), 1145-1154.
28. Busschbach, J. J.; Weijnen, T.; Nieuwenhuizen, M.; Oppe, S.; Badia, X.; Dolan, P.; et al. (2003). A comparison of EQ-5D time trade-off values obtained in Germany, the United Kingdom and Spain. In R. Brooks, R. Rabin, & F. de Charro (Eds.), The measurement and valuation of health status using EQ-5D: A European perspective (pp. 143-165). Dordrecht: Kluwer Academic.
29. Johnson, J. A.; Luo, N.; Shaw, J. W.; Kind, P.; Coons, S. J. (2005). Valuations of EQ-5D health states. Are the United States and United Kingdom different? Medical Care, 43(3), 221-228.
30. Kharroubi, S. A.; O'Hagan, A.; Brazier, J. E. (2010). A comparison of United States and United Kingdom EQ-5D health state valuations using a nonparametric Bayesian method. Statistics in Medicine, 29(15), 1622-1634.
31. Nan, L.; Johnson, J. A.; Shaw, J.; Coons, S. J. (2007). A comparison of EQ-5D index scores derived from the US and UK population-based scoring functions. Medical Decision Making, 27(3), 321-326.
32. Norman, R.; Cronin, P.; Viney, R.; King, M.; Street, D. (2009). International comparison in valuing EQ-5D health states: A review and analysis. Value in Health, 12(8), 1194-1200.
33. Gold, M. R.; Siegel, J. E.; Russell, L. B.; Weinstein, M. C. (1996). Cost-effectiveness in health and medicine. New York: Oxford University Press.
34. Kind, P. (2009). Valuing EQ-5D health states - a VAStly simpler solution? In J. Busschbach, R. Rabin, & F. De Charro (Eds.), 24th scientific plenary meeting of the EuroQoL group - Proceedings, 2009 Sept 13-15; Kijkduin-The Hague, The Netherlands (pp. 319-337). Rotterdam: EuroQoL Group Executive Office.
35. Leidl, R.; Reitmeir, P. (2011). A value set for the EQ-5D based on experienced health states. Development and testing for the German population. Pharmacoeconomics, 29(6), 521-534.
36. Rand-Hendriksen, K.; Augestad, L. A.; Kristiansen, I. S.; Stavem, K. (2012). Comparison of hypothetical and experienced EQ-5D valuations: Relative weights of five dimensions. Quality of Life Research, 21(6), 1005-1012.
37. Groot, W. (2000). Adaptation and scale of reference bias in self-assessments of quality of life. Journal of Health Economics, 19(3), 403-420.
38. Menzel, P.; Dolan, P.; Richardson, P.; Olsen, J. A. (2002). The role of adaptation to disability and disease in health state valuation: A preliminary normative analysis. Social Science and Medicine, 55(12), 2149-2158.
39. Ubel, P. A.; Loewenstein, G.; Jepson, C. (2003). Whose quality of life? A commentary exploring discrepancy between health state evaluations of patients and the general public. Quality of Life Research, 12(6), 599-607.
40. National Institute for Health and Clinical Excellence (NICE). (2008). Guide to the methods of technology appraisal. London: National Institute for Health and Clinical Excellence: London, 23 June 2008. http://www.nice.org.uk/ media/B52/A7/TAMethodsGuideUpdatedJune2008.pdf. Accessed 14 December 2012.
41. The Dental and Pharmaceutical Benefits Agency (TLV). (2003). General guidelines for economic evaluations from the Pharmaceutical Benefits Board (LFNAR 2003:2). Stockholm: The Dental and Pharmaceutical Benefits Agency. http://www.tlv.se/Upload/English/Guidelines-for-economic-evaluations-LFNAR-2003- 2.pdf. Accessed 14 December 2012.
42. Torrance, G. W. (1986). Measurement of health state utilities for economic appraisal: A review. Journal of Health Economics, 5(1), 1-30.
43. Bardage, C.; Isacson, D.; Ring, L.; Bingefors, K. (2003). A Swedish population-based study on the relationship between the SF-36 and health utilities to measure health in hypertension. Blood Pressure, 12(4), 203-210.
44. Lundberg, L.; Johannesson, M.; Isacson, D. G. L.; Borgquist, L. (1999). Health-state utilities in a general population in relation to age, gender and socioeconomic factors. European Journal of Public Health, 9(3), 211-217.
45. Williams, A. (1995). The measurement and valuation of health: A chronicle. Centre for Health Economics Discussion paper 136. York: University of York.
46. White, A. (1980). A heteroscedasticity consistent covariance matrix estimator and a direct test of heteroscedasticity. Econometrica, 48, 817-838.
47. ® 9.2. Procedures Guide (Second Ed, Vols. 1, 2, 3 and 4. Cary, NC: SAS Institute Inc.
48. Björk, S.; Norinder, A. (1999). The weighting exercise for the Swedish version of the EuroQol. Health Economics, 8(2), 117-126.
49. Greiner, W.; Claes, C.; Busschbach, J. J. V.; Graf van der Schulenburg, J. M. (2005). Validating the EQ-5D with time trade-off for the German population. European Journal of Health Economics, 6(2), 124-130.
50. Lamers, L. M.; McDonnell, J.; Stalmeier, P. F. M.; Krabbe, P. F. M.; Busschbach, J. J. V. (2006). The Dutch tariff: results and arguments for an effective design for national EQ-5D valuation studies. Health Economics, 15(10), 1121-1132.
51. Tongsiri, S.; Cairns, J. (2011). Estimating population-based values for EQ-5D health states in Thailand. Value in Health, 14(8), 1142-1145.
52. Badia, X.; Roset, M.; Herdman, M. (1999). Inkonsistent responses in the three preference-elicitation methods for health states. Social Science and Medicine, 49, 943-950.
53. Wittrup-Jensen, K. U.; Lauridsen, J.; Gudex, C.; Pedersen, K. M. (2009). Generation of a Danish TTO value set for EQ-5D health states. Scandinavian Journal of Public Health, 37(5), 459-466.
54. Polsky, D.; Wilke, R. J.; Scott, K.; Schulman, K. A.; Glick, H. (2001). A comparison of scoring weights for EuroQol derived from patients and the general public. Health Economics, 10(1), 27-37.
55. Zethraeus, N.; Johannesson, M. (1999). A comparison of patient and social tariff values derived from the time trade-off method. Health Economics, 8(6), 541-545.
56. Björk, S.; Althin, R. (1991). Health states considered worse than being dead. In S. Björk (Ed.), EuroQol Conference Proceedings, IHE Working paper, 1991 Sept, Lund, Sweden (pp. 83-86). Lund: The Swedish Institute for Health Economics (IHE).
57. Macran, S.; Kind, P. (2001). 'Death' and the valuation of health-related quality of life. Medical Care, 39(3), 217-227.
58. Burström, K.; Johannesson, M.; Diderichsen, F. (2001). Swedish population health-related quality of life using the EQ-5D. Quality of Life Research, 10(7), 621-635.
59. van Doorslaer, E.; Jones, A. M. (2003). Inequalities in self-reported health: Validation of a new approach to measurement. Journal of Health Economics, 22(1), 61-87.
60. Lundberg, L.; Johannesson, M.; Isacson, D. G. L.; Borgquist, L. (1999). The relationship between health state utilities and the SF-36 in a general population. Medical Decision Making, 19(2), 128-140.
61. Dolan, P. (2009). NICE should value real experiences over hypothetical opinions. Nature, 462(7269), 35.
62. Leidl, R.; Reitmeir, P.; König, H. H.; Stark, R. (2012). The performance of a value set for the EQ-5D based on experienced health states in patients with inflammatory bowel disease. Value in Health, 15(1), 151-157.